Albaconazole

CAS No. 187949-02-6

Albaconazole( —— )

Catalog No. M36847 CAS No. 187949-02-6

Albaconazole (W-0027) is a small molecule fungal cytochrome P450 family member 51 (fungal CYP51A1) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 532 Get Quote
5MG 787 Get Quote
10MG 1074 Get Quote
25MG 1463 Get Quote
50MG 1822 Get Quote
100MG 2250 Get Quote
500MG 4410 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Albaconazole
  • Note
    Research use only, not for human use.
  • Brief Description
    Albaconazole (W-0027) is a small molecule fungal cytochrome P450 family member 51 (fungal CYP51A1) inhibitor.
  • Description
    Albaconazole (W-0027) is a small molecule fungal cytochrome P450 family member 51 (fungal CYP51A1) inhibitor. It is used in the treatment of fungal infections, skin and musculoskeletal disorders, and can be used in the study of vulvovaginal candidiasis, Chagas disease and genitourinary disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    P450 | Antifungal
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    187949-02-6
  • Formula Weight
    431.82
  • Molecular Formula
    C20H16ClF2N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@@]([C@@H](C)N1C(=O)C=2C(N=C1)=CC(Cl)=CC2)(CN3C=NC=N3)(O)C4=C(F)C=C(F)C=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ellagic Acid Dihydra...

    Ellagic Acid Dihydrate inhibit the CYP1A1-dependent activation of benzo[a]pyrene.

  • Gomisin G

    Gomisin G is a natural compound and exhibits potent anti-HIV activity (EC50: 0.006 μg/mL; therapeutic index: 300). It is a good substrate of CYP2C9.

  • Antihistamine-1

    Antihistamine-1 is an H1-antihistamine (Ki: 6.9 nM) with acceptable blood-brain barrier penetration and also an inhibitor of CYP2D6 and hERG channel (IC50s: 5.4 and 0.8 μM).